Piramal Pharma Ltd
₹238.91
+8.13
(+3.52%)
as on
What are INDmoney investors doing with Piramal Pharma shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
+1%
Searches for Piramal Pharma on INDmoney have increased by 1% over the last 30 days.
Investment activity on INDmoney
+63.38%
Investment activity in Piramal Pharma among INDmoney users has increased by 63.38% over the last 30 days.
Among the most traded stocks
34th
Piramal Pharma was the 34th most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
19 days
INDmoney investors hold Piramal Pharma shares for an average of 19 days.
Key Events for Piramal Pharma
Piramal Pharma Stock Performance
as on October 30, 2026 at 9:31 pm IST
Day's Low
Day's High
₹225.82₹240.00
5.48%
Downside
0.46%
Upside
52 Week's Low
52 Week's High
₹132.30₹240.0044.62%
Downside
0.46%
Upside
Piramal Pharma share price movements today
- Previous Close
- ₹230.78
- Open
- ₹229.95
- Volume
- 2.69Cr
- Upper Circuit
- ₹276.93
- Lower Circuit
- ₹184.63
- Day's Low - High
- ₹225.82 - ₹240.00
- 52 Week Low - High
- ₹132.30 - ₹240.00
Piramal Pharma Historical Returns
- 1 Month Return
- + 16.57 %
- 3 Month Return
- + 17.98 %
- 1 Year Return
- + 15.6 %
- 3 Year Return
- + 120.84 %
- 5 Year Return
- + 21.46 %
Piramal Pharma Fundamentals
as on October 30, 2026 at 4:01 pm IST
Market Cap
₹31,807.24 Cr
Return on Equity (ROE)
8.98
PE Ratio (TTM)
-146.06
Return on capital employed (ROCE)
10.77
Industry PE ratio
51.39
Beta (LTM)
1.1
P/B Ratio
2.22
Dividend Yield
0PEG Ratio
104.33
Quarterly Earnings Growth YOY
-105.07
EPS (TTM)
-2.46
Book Value
61.5
Piramal Pharma Stock Valuation
as on October 30, 2026 at 4:01 pm IST
Piramal Pharma in the last 5 years
Lowest (-1134.06x)
October 29, 2025
Today (-146.06x)
October 29, 2026
Industry (51.39x)
October 29, 2026
Highest (2011.42x)
June 25, 2024
Today’s Price to Earnings Ratio: -146.06x
Piramal Pharma Technical Analysis
Track how Piramal Pharma technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.03 | |
CCI (20) | -522.05 | Bullish |
RSI (14) | 41.43 | Neutral |
Momentum (10) | -1.26 | |
ADI (14) | 26.52 | |
Ultimate Oscillator (7,14,28) | 72.98 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 238.99 | |
EMA (20) | 238.95 | |
VWMA (20) | 239.03 | |
SMA (50) | 238.77 | |
EMA (50) | 238.44 | |
SMA (200) | 235.98 | Bullish |
EMA (200) | 236.48 | Bullish |
KAMA (200) | 238.74 | |
DEMA (200) | 238 | Bullish |
Piramal Pharma Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Piramal Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 31,807.24 | 4.29% | 0.71 | -326 | 8,869 | |
| HOLD | 16,998.80 | -0.63% | 0.62 | 150 | 2,268 | |
| BUY | 14,716.13 | 11.01% | 0.73 | 397 | 8,279 | |
| NA | 5,726.51 | -6.31% | 0.66 | 1,553 | 1,879 | |
| BUY | 12,377.93 | 33.17% | 0.68 | 281 | 1,703 |
Market expectation of Piramal Pharma Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
100.00%
Buy
0.00%
Hold
0.00%
Sell
Piramal Pharma Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Piramal Pharma Ltd Annual Profit & Loss
Figures in Rupees Crores
Piramal Pharma Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Piramal Pharma
Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Piramal Pharma
Sorted by largest increase in holding, month-over-month.
No buying activity data available right now
Mutual Funds Exiting Piramal Pharma
Sorted by largest decrease in holding, month-over-month.
Fund Name | Value of Holding | Decrease (MoM) | Holding % |
|---|---|---|---|
 HDFC Flexi Cap Fund -Direct Plan - Growth Option | ₹1,716.25 Cr | ₹98.64 Cr (-5.44%) | 1.37% |
Piramal Pharma Corporate Actions
View detailed summary of the earnings and dividend history of Piramal Pharma.
Piramal Pharma Ltd Earnings Results
Piramal Pharma Ltd’s net profit jumped 105.62% since last year same period to ₹5.58Cr in the Q2 2026-2027. On a quarterly growth basis, Piramal Pharma Ltd has generated 108.04% jump in its net profits since last 3-months.
Read MorePiramal Pharma Ltd Dividends May,2025
In the quarter ending March 2025, Piramal Pharma Ltd has declared dividend of ₹0.14 per share on 14 May 2025 - translating a dividend yield of 0.06%.
Read More about Dividends
Indices Featuring Piramal Pharma Stock
Check stock indices that include Piramal Pharma.
Insights on Piramal Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 12.52% to 13.65% in Sep 2026 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, PPLPHARMA stock has moved up by 18.3%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -69.39 Cr → 5.58 Cr (in ₹), with an average increase of 1343.6% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.37K Cr → 2.67K Cr (in ₹), with an average increase of 10.9% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Laurus Labs Ltd has given 135.3% return, outperforming this stock by 119.7%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 34.80% of holdings in Sep 2026 quarter
- NO EFFECT
Against Peers
In the last 3 years, Laurus Labs Ltd has given 520.3% return, outperforming this stock by 399.5%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 13.18% to 12.71% in Sep 2026 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 37.63% to 36.71% in Sep 2026 quarter
About Piramal Pharma Ltd
Revenue: ₹2,617.06Cr as on September 2026 (Q2 FY27)
Net Profit: ₹5.03Cr as on September 2026 (Q2 FY27)
Listing date: 19 Oct, 2022
Chairperson Name: Nandini Piramal
| Organisation | Piramal Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Nandini Piramal |
| E-voting on shares | Click here to vote |
FAQs
What is Piramal Pharma share price today?
Piramal Pharma share price today stands at ₹238.91 as on at the close of the market. Piramal Pharma share today touched a day high of ₹240 and a low of ₹225.82.
What is the 52 week high and 52 week low range for Piramal Pharma share?
Piramal Pharma touched a 52 week high of ₹240 and a 52 week low of ₹132.3. Piramal Pharma share price today i.e. is closed at ₹238.91, which is -0.45% down from its 52 week high and 80.58% up from its 52 week low.
What is Piramal Pharma's market capitalisation today?
Piramal Pharma market capitalisation is ₹31,807.24 Cr as on .
How to buy Piramal Pharma shares?
To buy Piramal Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for PPLPHARMA or Piramal Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Piramal Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Piramal Pharma trading volume today?
Piramal Pharma trading volume is 2.69Cr as on . This means that 2.69Cr shares of Piramal Pharma were bought and sold on the stock market during today's trading session.
What are INDmoney investors doing with Piramal Pharma shares right now?
Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Piramal Pharma have both increased over the past 30 days, and the average INDmoney investor holds the stock for 19 days. This reflects platform activity only and is not investment advice.